Financial Snapshot
What do HCA Healthcare’s latest financial snapshot metrics show?
Mixed. The strongest factor is Adjusted EBITDA of $1557B in Fiscal Year 2025, while the main concern is the debt-heavy balance sheet and thin cash cushion.
For the latest verified picture, this snapshot combines growth, profitability, cash generation, balance-sheet capacity, and capital efficiency through 2025 and 2026-03-31. For background on the business model, see HCA Healthcare, Inc. (HCA): History, Ownership, Mission, How It Works & Makes Money.
Of the four metrics, free cash flow deserves deeper analysis first because it shows whether HCA Healthcare can keep funding investment and servicing its debt.
Revenue Quality
Does HCA Healthcare, Inc.’s revenue growth produce quality earnings?
Strong. The clearest confirmation is that revenue growth is backed by higher net income and EPS, not just top-line expansion. Same-facility admissions and equivalent admissions also rose, which supports organic demand rather than purely financial engineering.
HCA Healthcare, Inc. is showing growth quantity and growth quality at the same time, which matters because investors want to see revenue expand in a way that also lifts operating income, net income, and EPS across compatible annual periods. If revenue rises but earnings lag, growth is less durable; here, the earnings line is keeping up.
| Measure | Latest Period | Previous Period | Quality Test | Investor Meaning |
|---|---|---|---|---|
| Revenue | $7560B in Fiscal Year 2025, 710% growth | $7060B in 2024 | Organic growth appears supported by admissions and volume trends | Repeatable demand is more credible than one-off revenue lift |
| Operating Income | Not supplied | Not supplied | Cannot verify whether operating income grew faster, slower, or differently | Profit leverage cannot be fully tested from the provided data |
| Net Income | $678B in Fiscal Year 2025 | Not supplied | Supported by operating results, with no unusual item detail supplied | Final earnings appear to confirm the revenue trend |
| Diluted EPS | $2833 in Fiscal Year 2025 | Not supplied | Per-share growth also reflects Weighted Average Shares Growth of -176% at 2026-03-31 | Shareholders saw stronger per-share results than the business total alone suggests |
How durable is HCA Healthcare, Inc.’s revenue growth?
Durability looks solid because healthcare demand is recurring and same-facility admissions increased 090% and same-facility equivalent admissions increased 130%. The biggest visibility limit is mix pressure, since outpatient surgeries declined 170% and outpatient services are about 3830% of total patient revenues.
- Demand Quality: Recurring patient demand and higher same-facility admissions support visibility, though outpatient mix remains more variable.
- Pricing and Volume: Volume appears to be the main verified driver; the split between price and mix is not fully supplied.
- Diversification: Outpatient services account for approximately 3830% of total patient revenues, so service-line concentration still matters.
That mix and volume pattern is why profitability and cash conversion deserve the next look. If you’re using this topic for a paper or case study, a structured SWOT Analysis, PESTLE Analysis, or Business Model Canvas can help organize the evidence clearly. For a deeper read, see HCA Healthcare, Inc. (HCA): History, Ownership, Mission, How It Works & Makes Money.
Margins and cash quality
How strong are HCA Healthcare’s margins and cash conversion?
Margins were solid but not untouchable: gross and operating margin were both about 14.96% in Q1 2026, while net margin was 8.48%. Reported earnings are only partly confirmed by cash data, since operating cash flow growth was negative and free cash flow growth was positive.
HCA Healthcare’s gross profit and operating income were both $286B on $1911B of revenue in Q1 2026, which points to stable core hospital economics. Net income was $162B, but interest expense of $58400M and income tax expense of $43000M show why net profit is lower than operating profit. Cash conversion looks mixed because earnings did not move in the same direction as cash flow indicators.
| Measure | Latest Period | Previous Period | Verified Driver | Investor Meaning |
|---|---|---|---|---|
| Gross Margin | 14.96% in Q1 2026 | Unavailable | Revenue of $1911B versus cost of revenue of $1625B | Product and service economics stayed positive, with enough spread left after direct costs. |
| Operating Margin | 14.96% in Q1 2026 | Unavailable | Operating income held at $286B, showing no visible drag from operating costs in the supplied data | Scale is still supporting operating efficiency. |
| Net Margin | 8.48% in Q1 2026 | Unavailable | Interest expense of $58400M and income tax expense of $43000M reduced profit after operations | Final profitability is weaker than operating profitability, so financing and taxes matter. |
| Operating Cash Flow | Unavailable; FMP 2026-03-31 showed Operating Cash Flow Growth: -1462% | Unavailable | The supplied data does not include a dollar figure, only a sharp decline in growth | Accounting earnings are not clearly converting into operating cash. |
| Free Cash Flow | Unavailable; FMP 2026-03-31 showed Free Cash Flow Growth: 287% | Unavailable | Projected fiscal year 2026 capital expenditures of $500B–$550B support capacity and digital transformation but absorb cash | Remaining cash may be tighter after reinvestment, even if free cash flow is improving. |
What most affects HCA Healthcare’s cash conversion?
Interest expense is the clearest drag on cash conversion, and the projected $500B–$550B capital spending range also keeps cash deployment heavy.
- Main Driver: Interest expense and high capital spending pressure cash; both look structural rather than temporary.
- Evidence Gap: The supplied data does not show operating cash flow or free cash flow dollar amounts.
- Metric to Monitor: Watch operating cash flow, free cash flow, and interest expense next.
If you’re using this topic for a paper or case study, a structured SWOT Analysis, PESTLE Analysis, or Business Model Canvas can help you organize the research into clear arguments. For a fuller company background, see HCA Healthcare, Inc. (HCA): History, Ownership, Mission, How It Works & Makes Money.
Debt Load Check
Can HCA Healthcare support its debt and liquidity needs?
Mixed. HCA Healthcare has the operating scale to support the business, but its debt load and interest burden are meaningful. The main protection is cash-generating capacity from a large hospital network; the main concern is how much flexibility debt and interest expense leave for reinvestment.
Cash alone does not answer the solvency question. Investors should look at working capital, asset quality, debt service, liquidity, refinancing risk, and equity support together. For a related ownership-angle, see Exploring HCA Healthcare, Inc. (HCA) Investor Profile: Who's Buying and Why?
| Area | Latest Evidence | Assessment | Investor Meaning |
|---|---|---|---|
| Cash and Working Capital | $104B cash and cash equivalents at 2026-03-31; receivables growth 421%; inventory growth 176%; asset growth 120%. | Mixed | Cash helps near-term coverage, but the prompt does not provide current liabilities or a full liquidity ratio, so short-term pressure cannot be fully measured. |
| Total and Net Debt | $4649B total indebtedness at 2025-12-31; $104B cash and cash equivalents at 2026-03-31; FMP shows minus cash and cash equivalents of $94000M and add total debt of $4985B. | Weak | Debt is large relative to cash, so leverage can limit flexibility even if operating earnings are strong. |
| Debt Service and Refinancing | Q1 2026 interest expense of $58400M; no maturity or covenant data supplied. | Mixed | Interest costs are material, so operating income and cash flow must stay strong to avoid pressure on future investment. |
| Asset Quality | $6072B total assets at 2025-12-31; receivables growth 421%; inventory growth 176%; asset growth 120%. | Mixed | Asset growth supports scale, but fast receivables and inventory growth can tie up cash and deserve monitoring. |
| Liabilities and Equity | Latest verified total liabilities and shareholders' equity were not supplied in the prompt. | Mixed | The book capital base cannot be checked here, so liability coverage needs the full balance sheet. |
What balance-sheet risk matters most for HCA Healthcare?
Debt service risk matters most. The strongest verified issue is the $58400M Q1 2026 interest expense, which makes leverage and cash generation the key variables to watch.
- Current Exposure: $4649B total indebtedness at 2025-12-31 versus $104B cash and cash equivalents at 2026-03-31.
- Protection: Large operating scale and cash-generating capacity from the hospital network.
- Warning Signal: Rising interest burden or slower cash generation that reduces room for reinvestment.
Capital Efficiency
Are HCA Healthcare’s returns funded by durable internal cash generation?
HCA Healthcare’s capital efficiency looks Strong, and internal cash appears sufficient for reinvestment needs. The evidence is strongest in consistent buybacks, dividends, and acquisitions, but leverage-backed capital returns can still pressure flexibility if operating cash flow weakens.
Return measures need leverage, asset intensity, capital expenditure, working capital, and outside funding to be judged fairly. HCA Healthcare’s supplied data does not include ROIC, ROE, or ROA, so capital allocation evidence is the better test here. The link between cash generation and returns matters because heavy buybacks or acquisitions can outpace internally funded growth.
| Capital Measure | Latest Evidence | Quality Test | Investor Meaning |
|---|---|---|---|
| ROIC | Unavailable in the supplied data. | Cannot be verified directly; capital efficiency must be inferred from spending and payout behavior. | Investors should look for whether operating cash can keep funding growth without eroding value. |
| ROE and ROA | Unavailable in the supplied data. | ROE would be influenced by leverage; ROA would reflect HCA Healthcare’s asset intensity, but neither ratio is provided. | Shareholder return quality cannot be judged from the ratios alone here, so balance-sheet use matters. |
| Maintenance and Growth Investment | $500B–$550B projected capital expenditures for Fiscal Year 2026; $260M in Q1 2026 acquisitions; $110M Catholic Medical Center acquisition on February 01, 2026. | Spending is clearly ongoing and includes both expansion and acquisitions, but the maintenance-growth split is not fully disclosed. | HCA Healthcare is still funding hospital and acquisition growth, which supports scale but requires steady cash generation. |
| Internal Funding Capacity | Fiscal Year 2025 total share repurchases: 2674M shares at a cost of approximately $1007B; Q1 2026 share repurchases: $157B; fiscal year 2025 dividends paid: $679M; March 31, 2026 quarterly cash dividend: $078 per share, up from $072 in 2025; January 27, 2026 board authorization for up to $1000B of common stock repurchases. | Internal cash appears to support repurchases, dividends, and acquisitions, but the scale of buybacks makes flexibility more sensitive to earnings and cash flow. | Capital returns look internally funded today, yet aggressive repurchases can reduce room for slower periods or larger investment needs. |
Are HCA Healthcare’s returns on capital sustainable?
The strongest durability source is recurring cash generation from operations, while the main weakening risk is heavy buybacks or acquisitions that depend on sustained leverage and resilient EBITDA and EPS.
- Operating Source: Resilient EBITDA and EPS support cash generation and the ability to fund returns.
- Funding Requirement: $500B–$550B of projected capital expenditures, plus acquisition spending and repurchases.
- Durability Test: Returns weaken if cash flow coverage slips while repurchases and acquisition spending remain high.
Debt Load
How resilient is HCA Healthcare, and which warning signs matter most?
HCA Healthcare’s resilience looks Mixed. The main buffer is its scale across 190 hospitals and about 2,500 sites of care, plus 47M annual patient encounters. The most important verified warning sign is heavy leverage: Total Indebtedness: $4649B and Q1 2026 Interest Expense: $58400M.
HCA Healthcare can still fund essential operations because demand is broad and recurring, and the Resiliency Program targets $400M in savings during 2026. But resilience weakens if margin pressure becomes persistent, since labor costs are high, reimbursement can shift, and cash flow must absorb debt service, capex, and staffing needs. Mission Statement, Vision, & Core Values (2026) of HCA Healthcare, Inc. (HCA)
| Pressure | Financial Effect | Existing Protection | Warning Signal |
|---|---|---|---|
| Revenue or Margin Pressure | Winter storms and a mild respiratory season caused an estimated $180M reduction in Adjusted EBITDA in Q1 2026, which weakens operating leverage, cash flow, and debt capacity if it persists. | HCA Healthcare’s large, diversified network of 190 hospitals and about 2,500 sites of care supports recurring patient volumes. | Another quarter of falling Adjusted EBITDA or weaker same-facility margin would confirm deterioration. |
| Working-Capital or Investment Pressure | Payroll and Benefits Expense of $3120B in Fiscal Year 2025 and higher labor costs can absorb cash needed for capital spending, especially with industry-wide nursing shortages. | Internal funding capacity is supported by scale, and the Resiliency Program is aimed at $400M in 2026 savings. | Rising labor expense, slower operating cash flow, or capex pressure would show cash strain. |
| Interest or Refinancing Pressure | High leverage and Q1 2026 Interest Expense: $58400M can reduce free cash flow and limit flexibility if borrowing costs rise or maturities tighten. | HCA Healthcare’s size and cash generation help support access to financing, and Medicaid supplemental payments added a $200M net benefit to Adjusted EBITDA in Q1 2026. | Higher interest expense, weaker coverage, or refinancing stress would signal rising pressure. |
Which financial warning signs should investors monitor at HCA Healthcare?
The strongest signals are recurring Adjusted EBITDA pressure, rising labor expense, and heavier interest burden. Confirmed deterioration would be another quarter of margin decline; a future risk is whether storm, respiratory, and exchange-related headwinds become recurring.
Leverage and Interest Expense
High debt and $58400M of Q1 2026 interest expense are the clearest strain points. The offset is scale and cash generation. Watch debt levels, interest expense, and coverage for signs that financing flexibility is narrowing.
Recurring Margin Headwinds
Winter storms, a mild respiratory season, and insurance exchange-related coverage changes together hit EBITDA. The mitigating factor is HCA Healthcare’s broad network. Watch whether these effects fade or stay embedded in quarterly margins.
Labor Cost Pressure
Payroll and Benefits Expense of $3120B shows how staffing costs can absorb cash. The offset is the Resiliency Program. Watch payroll growth, staffing availability, and operating cash flow.
Balance Sheet Watch
What does HCA Healthcare’s financial health mean for investors?
Overall rating: Mixed. The strongest factor is EBITDA scale and recurring demand. The weakest factor is the debt-heavy balance sheet. The most important issue for the investment case is liquidity and leverage discipline.
| Financial Factor | Rating | Evidence and Investor Meaning |
|---|---|---|
| Revenue and Earnings Quality | Strong | Fiscal Year 2025 Total Revenue was $7560B, and Q1 2026 Revenue was $1911B with year-over-year growth, showing durable demand and per-share support. |
| Profitability and Cash | Mixed | Q1 2026 Net Margin was 972% and Adjusted EBITDA was $380B, but Operating Cash Flow Growth was -1462% at 2026-03-31. |
| Balance Sheet and Liquidity | Weak | Cash of $94000M is small versus total debt of $4985B at 2026-03-31, so debt service and refinancing deserve close attention. |
| Capital Efficiency | Mixed | Buybacks and dividends support per-share returns, but they compete with Fiscal Year 2026 Projected Capital Expenditures of $500B–$550B. |
| Financial Resilience | Mixed | Scale and savings programs help offset weather, exchange, labor, and interest pressure, but the cushion is thinner because leverage is high. |
- What Supports the Thesis: Strong EBITDA scale plus recurring demand and shareholder returns point to profitable growth.
- What Challenges the Thesis: Debt-heavy leverage and weak liquidity make cash discipline the main uncertainty.
- What to Monitor: Adjusted EBITDA, Interest Expense, Free Cash Flow Growth.
This scorecard is most useful for forecasting scenarios and building valuation assumptions around earnings durability, cash conversion, and leverage pressure. If you’re using this topic for a paper or case study, a structured SWOT Analysis, PESTLE Analysis, or Business Model Canvas can help you organize the research into clear arguments. Exploring HCA Healthcare, Inc. (HCA) Investor Profile: Who's Buying and Why?
FAQ
What Do Investors Ask About 's Financial Health?
Investors most often ask about the company's revenue quality, profitability, cash generation, debt, liquidity, capital efficiency, and ability to withstand financial pressure.
Why does HCA still need heavy capital spending?
HCA plans Fiscal Year 2026 Projected Capital Expenditures of $500B–$550B for bed capacity expansion and digital transformation The spending supports growth and efficiency, but it also reduces financial flexibility when debt and interest expense are already high
How do share repurchases affect cash flexibility?
Repurchases can improve per-share results by reducing share count, but they also use cash that could otherwise support debt reduction, capex, or acquisitions HCA repurchased $157B of common stock in Q1 2026 after repurchasing 2674M shares in Fiscal Year 2025
What supports HCA’s debt servicing capacity?
HCA’s debt servicing capacity is supported by scale, recurring healthcare demand, and Adjusted EBITDA of $380B in Q1 2026 The constraint is the size of debt and Q1 2026 Interest Expense of $58400M, which investors should monitor closely
Which metric best shows cash conversion?
Operating cash flow and free cash flow trends are the best indicators, but dollar values were not supplied here FMP shows Operating Cash Flow Growth: -1462% and Free Cash Flow Growth: 287% at 2026-03-31, which points to mixed conversion
Can liquidity support expansion and acquisitions?
Liquidity can support expansion if earnings and cash flow remain strong, but the cushion is limited At 2026-03-31, HCA had cash of $94000M and total debt of $4985B, while Q1 2026 acquisitions used $260M